Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats

Journal of Nutrition

Volumn 139, Issue 10, 2009, Pages 1908-1913

  Legette, Leecole L ^a   Martin, Berdine R ^a   Shahnazari, Mohammad ^a   Lee, Wang Hee ^a   Helferich, William G ^b   Qian, Junqi ^c   Waters, David J ^d   Arabshahi, Alireza ^e   Barnes, Stephen ^e   Welch, Jo ^a   Bostwick, David G ^c   Weaver, Connie M ^a  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c BOSTWICK LABORATORIES   (United States)

^d PURDUE UNIVERSITY   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; EQUOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE METABOLISM; BREAST EPITHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOSE RESPONSE; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG TISSUE LEVEL; ENDOMETRIUM; EXPERIMENTAL MODEL; FEMALE; FEMUR; HEART; INTESTINE; KIDNEY; LIVER; NONHUMAN; OVARIECTOMY; PARAMETER; RAT; SHAM PROCEDURE; TIBIA; TISSUE DISTRIBUTION; TRABECULAR BONE; UTERUS WEIGHT;

ANIMALS; BONE AND BONES; BONE DENSITY; CALCIUM; DIETARY SUPPLEMENTS; FEMALE; ISOFLAVONES; LETHAL DOSE 50; ORGAN SIZE; OVARIECTOMY; PHYTOESTROGENS; RATS; RATS, SPRAGUE-DAWLEY; UTERUS;

RATTUS;

EID: 70349308391     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.109.108225     Document Type: Article

References (36)

1. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333 (Pubitemid 34761611)
2. Setchell KD, Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr. 2003; 78 Suppl 3:S593-609. (Pubitemid 40012554)
3. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165-176 (Pubitemid 28180851)
4. Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, Gaudio A, Mazzaferro S, Frisina A, et al. OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. J Bone Miner Res. 2008;23:715-720 (Pubitemid 351575025)
5. Phrakonkham P, Chevalier J, Desmetz C, Pinnert MF, Berges R, Jover E, Davicco MJ, Bennetau-Pelissero C, Coxam V, et al. Isoflavonoid-based bone-sparing treatments exert a low activity on reproductive organs and on hepatic metabolism of estradiol in ovariectomized rats. Toxicol Appl Pharmacol. 2007;224:105-115 (Pubitemid 47494513)
6. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem. 2004;12:1559-1567 (Pubitemid 38304880)
7. Bolca S, Possemiers S, Herregat A, Huybrechts I, Heyerick A, De Vriese S, Verbruggen M, Depypere H, De Keukeleire D, et al. Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women. J Nutr. 2007;137:2242-2246 (Pubitemid 47529584)
8. Frankenfeld CL, McTiernan A, Thomas WK, LaCroix K, McVarish L, Holt VL, Schwartz SM, Lampe JW. Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes. Maturitas. 2006;53:315-324 (Pubitemid 43163067)
9. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132:3577-3584 (Pubitemid 35435031)
10. Song KB, Atkinson C, Frankenfeld CL, Jokela T, Wahala K, Thomas WK, Lampe JW. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr. 2006;136:1347-1351
11. Ward WE, Kim S, Chan D, Fonseca D. Serum equol, bone mineral density and biomechanical bone strength differ among four mouse strains. J Nutr Biochem. 2005;16:743-749 (Pubitemid 41624796)
12. Rachon D, Menche A, Vortherms T, Seidlova-Wuttke D, Wuttke W. Effects of dietary equol administration on the mammary gland in ovariectomized Sprague-Dawley rats. Menopause. 2008;15:340-345 (Pubitemid 351354997)
13. Rachon D, Vortherms T, Seidlova-Wuttke D, Menche A, Wuttke W. Uterotropic effects of dietary equol administration in ovariectomized Sprague-Dawley rats. Climacteric. 2007;10:416-426 (Pubitemid 47402937)
14. Selvaraj V, Zakroczymski MA, Naaz A, Mukai M, Ju YH, Doerge DR, Katzenellenbogen JA, Helferich WG, Cooke PS. Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice. Biol Reprod. 2004;71:966-972 (Pubitemid 39108660)
15. Rachon D, Seidlova-Wuttke D, Vortherms T, Wuttke W. Effects of dietary equol administration on ovariectomy induced bone loss in Sprague-Dawley rats. Maturitas. 2007;58:308-315 (Pubitemid 350086841)
16. Mathey J, Mardon J, Fokialakis N, Puel C, Kati-Coulibaly S, Mitakou S, Bennetau-Pelissero C, Lamothe V, Davicco MJ, et al. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol. Osteoporos Int. 2007;18:671-679 (Pubitemid 46525554)
17. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939-1951
18. Persky VW, Turyk ME, Wang L, Freels S, Chatterton R Jr, Barnes S, Erdman J Jr, Sepkovic DW, Bradlow HL, et al. Effect of soy protein on endogenous hormones in postmenopausal women. Am J Clin Nutr. 2002;75:145-153 (Pubitemid 34008032)
19. Sites CK, Cooper BC, Toth MJ, Gastaldelli A, Arabshahi A, Barnes S. Effect of a daily supplement of soy protein on body composition and insulin secretion in postmenopausal women. Fertil Steril. 2007;88:1609-1617 (Pubitemid 350216852)
20. Weaver C, Janle E, Martin B, Browne S, Guiden H, Lachcik P, Lee WH. Dairy vs. calcium carbonate in promoting peak bone mass and bone maintenance during subsequent calcium deficiency. J Bone Miner Res. 2009;24:1411-1419
21. Cai DJ, Zhao Y, Glasier J, Cullen D, Barnes S, Turner CH, Wastney M, Weaver CM. Comparative effect of soy protein, soy isoflavones, and 17beta-estradiol on bone metabolism in adult ovariectomized rats. J Bone Miner Res. 2005;20:828-839 (Pubitemid 40571640)
22. Arjmandi BH, Getlinger MJ, Goyal NV, Alekel L, Hasler CM, Juma S, Drum ML, Hollis BW, Kukreja SC. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr. 1998; 68 Suppl 6:S1358-63. (Pubitemid 28550912)
23. Bahr JM, Nakai M, Rivera A, Walsh J, Evans GL, Lotinun S, Turner RT, Black M, Jeffery EH. Dietary soy protein and isoflavones: minimal beneficial effects on bone and no effect on the reproductive tract of sexually mature ovariectomized Sprague-Dawley rats. Menopause. 2005;12:165-173 (Pubitemid 40464285)
24. Wu J, Wang X, Chiba H, Higuchi M, Nakatani T, Ezaki O, Cui H, Yamada K, Ishimi Y. Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice. Metabolism. 2004;53:942-948 (Pubitemid 38829472)
25. Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, et al. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr. 2005;81:1072-1079 (Pubitemid 41724948)
26. Wu J, Oka J, Higuchi M, Tabata I, Toda T, Fujioka M, Fuku N, Teramoto T, Okuhira T, et al. Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial. Metabolism. 2006;55:423-433
27. Fujioka M, Uehara M, Wu J, Adlercreutz H, Suzuki K, Kanazawa K, Takeda K, Yamada K, Ishimi Y. Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice. J Nutr. 2004;134:2623-2627 (Pubitemid 39315263)
28. Lamartiniere CA, Wang J, Smith-Johnson M, Eltoum IE. Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol Sci. 2002;65:228-238 (Pubitemid 34121115)
29. Ohta A, Uehara M, Sakai K, Takasaki M, Adlercreutz H, Morohashi T, Ishimi Y. A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice. J Nutr. 2002;132:2048-2054 (Pubitemid 34742898)
30. Zafar TA, Weaver CM, Jones K, Moore DR II, Barnes S. Inulin effects on bioavailability of soy isoflavones and their calcium absorption enhancing ability. J Agric Food Chem. 2004;52:2827-2831
31. Drapeau MS, Streeter MA. Modeling and remodeling responses to normal loading in the human lower limb. Am J Phys Anthropol. 2006;129:403-409
32. Saxon LK, Robling AG, Castillo AB, Mohan S, Turner CH. The skeletal responsiveness to mechanical loading is enhanced in mice with a null mutation in estrogen receptor-beta. Am J Physiol Endocrinol Metab. 2007;293:E484-91. (Pubitemid 47205091)
33. Cooke PS, Buchanan DL, Young P, Setiawan T, Brody J, Korach KS, Taylor J, Lubahn DB, Cunha GR. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci USA. 1997;94:6535-6540 (Pubitemid 27270720)
34. Jefferson WN, Padilla-Banks E, Clark G, Newbold RR. Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;777:179-189 (Pubitemid 35257871)
35. Padilla-Banks E, Jefferson WN, Newbold RR. The immature mouse is a suitable model for detection of estrogenicity in the uterotropic bioassay. Environ Health Perspect. 2001;109:821-826 (Pubitemid 32910305)
36. Heemstra JM, Kerrigan SA, Doerge DR, Helferich WG, Boulanger WA. Total synthesis of (S)-equol. Org Lett. 2006;8:5441-5443